{"id":"https://openalex.org/W2062480465","doi":"https://doi.org/10.1016/s0140-6736(73)92114-4","title":"COMPARATIVE EFFICACY OF SULPHONAMIDE AND CO-TRIMOXAZOLE","display_name":"COMPARATIVE EFFICACY OF SULPHONAMIDE AND CO-TRIMOXAZOLE","publication_year":1973,"publication_date":"1973-09-01","ids":{"openalex":"https://openalex.org/W2062480465","doi":"https://doi.org/10.1016/s0140-6736(73)92114-4","mag":"2062480465","pmid":"https://pubmed.ncbi.nlm.nih.gov/4125033"},"language":"en","primary_location":{"id":"doi:10.1016/s0140-6736(73)92114-4","doi":"https://doi.org/10.1016/s0140-6736(73)92114-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0140-6736(73)92114-4","pdf_url":null,"source":{"id":"https://openalex.org/S49861241","display_name":"The Lancet","issn_l":"0099-5355","issn":["0099-5355","0140-6736","1474-547X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110010240","display_name":"RICHARD W. LACEY","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802901496","display_name":"Bristol Royal Infirmary","ror":"https://ror.org/031p4kj21","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802901496","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R.W. Lacey","raw_affiliation_strings":["Department of Bacteriology, Bristol Royal Infirmary, Bristol 2, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Bacteriology, Bristol Royal Infirmary, Bristol 2, United Kingdom","institution_ids":["https://openalex.org/I2802901496"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J.D. Anderson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802901496","display_name":"Bristol Royal Infirmary","ror":"https://ror.org/031p4kj21","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802901496","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J.D. Anderson","raw_affiliation_strings":["Department of Bacteriology, Bristol Royal Infirmary, Bristol 2, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Bacteriology, Bristol Royal Infirmary, Bristol 2, United Kingdom","institution_ids":["https://openalex.org/I2802901496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104360273","display_name":"Evelyn L. Lewis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802901496","display_name":"Bristol Royal Infirmary","ror":"https://ror.org/031p4kj21","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802901496","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"E.L. Lewis","raw_affiliation_strings":["Department of Bacteriology, Bristol Royal Infirmary, Bristol 2, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Bacteriology, Bristol Royal Infirmary, Bristol 2, United Kingdom","institution_ids":["https://openalex.org/I2802901496"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108094704","display_name":"W. Allan Gillespie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802901496","display_name":"Bristol Royal Infirmary","ror":"https://ror.org/031p4kj21","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802901496","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"W.A. Gillespie","raw_affiliation_strings":["Department of Bacteriology, Bristol Royal Infirmary, Bristol 2, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Bacteriology, Bristol Royal Infirmary, Bristol 2, United Kingdom","institution_ids":["https://openalex.org/I2802901496"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2802901496"],"apc_list":{"value":7890,"currency":"USD","value_usd":7890},"apc_paid":null,"fwci":1.594,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.81414141,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"302","issue":"7827","first_page":"509","last_page":"509"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.7045999765396118,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.7045999765396118,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.11789999902248383,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14275","display_name":"Historical Medical Research and Treatments","score":0.020600000396370888,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sulfonamides","display_name":"sulfonamides","score":0.8730000257492065},{"id":"https://openalex.org/keywords/trimethoprim-sulfamethoxazole","display_name":"trimethoprim-sulfamethoxazole","score":0.9309999942779541},{"id":"https://openalex.org/keywords/antimicrobial-efficacy","display_name":"antimicrobial efficacy","score":0.6499999761581421},{"id":"https://openalex.org/keywords/comparative-efficacy","display_name":"drug efficacy comparison","score":0.4090000092983246}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47435224056243896}],"mesh":[{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004352","descriptor_name":"Drug Resistance, Microbial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004926","descriptor_name":"Escherichia coli","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008722","descriptor_name":"Methods","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013420","descriptor_name":"Sulfamethoxazole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014295","descriptor_name":"Trimethoprim","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014552","descriptor_name":"Urinary Tract Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0140-6736(73)92114-4","doi":"https://doi.org/10.1016/s0140-6736(73)92114-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0140-6736(73)92114-4","pdf_url":null,"source":{"id":"https://openalex.org/S49861241","display_name":"The Lancet","issn_l":"0099-5355","issn":["0099-5355","0140-6736","1474-547X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet","raw_type":"journal-article"},{"id":"pmid:4125033","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/4125033","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lancet (London, England)","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1599877063","https://openalex.org/W1994186110","https://openalex.org/W2021099322","https://openalex.org/W2038018238","https://openalex.org/W2049571195","https://openalex.org/W2084124152","https://openalex.org/W2143491269"],"related_works":["https://openalex.org/W2071780666","https://openalex.org/W2121155698","https://openalex.org/W4299525036","https://openalex.org/W4242323636","https://openalex.org/W4251617630","https://openalex.org/W2095155835","https://openalex.org/W2470528969","https://openalex.org/W1992031022","https://openalex.org/W2764676366","https://openalex.org/W2472656630"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}